Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.
Related Posts
Snowflake shares pop 14% on earnings and revenue beat
Snowflake reported better-than-expected results on the top and bottom lines.
Stick to high-quality dividend payers amid tariff turmoil, such as this energy stock, investor Tom Hulick says
Tom Hulick, CEO at Strategy Asset Managers, joined CNBC’s “Power Lunch” to give his opinions on a trio of stocks.
Shopify stock slips on light guidance, company notes tariff ‘uncertainty’
Shopify said it expects its merchants to have less exposure to President Donald Trump’s sweeping tariffs, while acknowledging there’s “uncertainty ahead.”